🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Phase 1, Randomized, Double Blind, Sponsor Open, Placebo Controlled, Sequ...
Status
Completed
Location
Pfizer New Haven Clinical Research Unit
Start Date
2015-06
Trial ID
NCT02485769
Treatments Being Tested
This is a study with 3 kinase inhibitors (PF 06650833, PF 06700841 and PF 0...
Status
Completed
Location
The University Of Alabama At Birmingham
Start Date
2019-12-02
Trial ID
NCT04092452
Treatments Being Tested
This is a Phase 1, open-label, single-dose, within-cohort randomized, 2-way...
Status
Completed
Location
New Haven Clinical Research Unit
Start Date
2015-11
Trial ID
NCT02609139
Treatments Being Tested
This is a Phase 1, open label, fixed sequence study of the effect of multip...
Status
Completed
Location
Qps-Mra, Llc
Start Date
2021-10-08
Trial ID
NCT05064332
Treatments Being Tested
The purpose of this study is to evaluate the potential pharmacokinetic (PK)...
Status
Completed
Location
Pfizer New Haven Clinical Research Unit
Start Date
2019-02-07
Trial ID
NCT03827668
Treatments Being Tested
The aim of the current clinical study is to evaluate the efficacy and safet...
Status
Unknown
Location
Bronx-Lebanon Hospital Center Health Care System
Start Date
2021-01-06
Trial ID
NCT04933799
Treatments Being Tested
Bioavailability and food effect of 2 formulations of PF-06650833 in healthy...
Status
Completed
Location
Pfizer Clinical Research Unit
Start Date
2017-09-08
Trial ID
NCT03308110
Treatments Being Tested
Dual objectives of increased efficacy compared to currently available SoC R...
Status
Completed
Location
,,UMHAT - Georgi Stranski" EAD
Start Date
2020-07-29
Trial ID
NCT04413617
Treatments Being Tested
This is a Phase 2, multicenter, randomized, double blind, double dummy, pla...
Status
Completed
Location
Clinical and Translational Research Center of Alabama, PC
Start Date
2016-11-10
Trial ID
NCT02996500
Treatments Being Tested
This single ascending dose study is the first evaluation of PF-06650833 in ...
Status
Completed
Location
New Haven Clinical Research Unit
Start Date
2014-09
Trial ID
NCT02224651
Treatments Being Tested